RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chenguang Biotech Group Co Stock

Chenguang Biotech Group Co Liabilities 2024

Chenguang Biotech Group Co Liabilities

5.07 B CNY

Ticker

300138.SZ

ISIN

CNE100000WC5

In 2024, Chenguang Biotech Group Co's total liabilities amounted to 5.07 B CNY, a 34.86% difference from the 3.76 B CNY total liabilities in the previous year.

Chenguang Biotech Group Co Aktienanalyse

What does Chenguang Biotech Group Co do?

Chenguang Biotech Group Co Ltd is a professional manufacturer of high-quality biological products. The company is headquartered in China and was founded in 2009. Since then, the company has quickly become one of the leading companies in the biotechnology products industry. Chenguang Biotech Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Chenguang Biotech Group Co's Liabilities

Chenguang Biotech Group Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Chenguang Biotech Group Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Chenguang Biotech Group Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Chenguang Biotech Group Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Chenguang Biotech Group Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Chenguang Biotech Group Co stock

What is the level of liabilities of Chenguang Biotech Group Co this year?

Chenguang Biotech Group Co has a debt balance of 5.07 B CNY this year.

What were the liabilities of Chenguang Biotech Group Co compared to the previous year?

The liabilities of Chenguang Biotech Group Co have increased by 34.86% increased compared to the previous year.

What are the consequences of high debt for investors of Chenguang Biotech Group Co?

High liabilities can pose a risk for investors of Chenguang Biotech Group Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Chenguang Biotech Group Co?

Low liabilities mean that Chenguang Biotech Group Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Chenguang Biotech Group Co affect the company?

An increase in liabilities of Chenguang Biotech Group Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Chenguang Biotech Group Co affect the company?

A decrease in the liabilities of Chenguang Biotech Group Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Chenguang Biotech Group Co?

Some factors that can influence the liabilities of Chenguang Biotech Group Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Chenguang Biotech Group Co so important for investors?

The liabilities of Chenguang Biotech Group Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Chenguang Biotech Group Co take to modify the liabilities?

To change its liabilities, Chenguang Biotech Group Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Chenguang Biotech Group Co pay?

Over the past 12 months, Chenguang Biotech Group Co paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 2.07 %. For the coming 12 months, Chenguang Biotech Group Co is expected to pay a dividend of 0.18 CNY.

What is the dividend yield of Chenguang Biotech Group Co?

The current dividend yield of Chenguang Biotech Group Co is 2.07 %.

When does Chenguang Biotech Group Co pay dividends?

Chenguang Biotech Group Co pays a quarterly dividend. This is distributed in the months of May, July, June, July.

How secure is the dividend of Chenguang Biotech Group Co?

Chenguang Biotech Group Co paid dividends every year for the past 16 years.

What is the dividend of Chenguang Biotech Group Co?

For the upcoming 12 months, dividends amounting to 0.18 CNY are expected. This corresponds to a dividend yield of 2.31 %.

In which sector is Chenguang Biotech Group Co located?

Chenguang Biotech Group Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Chenguang Biotech Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chenguang Biotech Group Co from 6/13/2024 amounting to 0.13 CNY, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Chenguang Biotech Group Co pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of Chenguang Biotech Group Co in the year 2023?

In the year 2023, Chenguang Biotech Group Co distributed 0.13 CNY as dividends.

In which currency does Chenguang Biotech Group Co pay out the dividend?

The dividends of Chenguang Biotech Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chenguang Biotech Group Co

Our stock analysis for Chenguang Biotech Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chenguang Biotech Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.